comprehensive -WSS

comprehensive

author：knowledge 2025-09-28 19:25:43 - browse：6

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Kim Kardashian sparks debate on benefits of full

WSS

Novo acquires Inversago for up to $1 billion

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

GOP presidential candidates start declaring their loyalty

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Covid's long

Reanimated hearts work just as well for transplants, study finds

focus

comprehensive

leisure time

Psychedelics group wrestles with new pharma identity

Covid's long

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Biden administration plans revamp of organ transplant system

Drug repurposing or repositioning? The language matters

Xenotransplantation trials will require adjusting expectations, experts say

Activists slam private health insurers over coverage restrictions

GOP presidential candidates start declaring their loyalty

How to save PrEP access — and even expand it

Biogen nominates mother of director’s child to replace him on board

focus

Where are patients getting their prescriptions for GLP

Millions may soon lose Medicaid when they don't have to

Biden administration plans revamp of organ transplant system

Living organ donors deserve priority status for transplants

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Reanimated hearts work just as well for transplants, study finds

entertainment

focus

entertainment

leisure time